RCKT Latest Press Releases

-- January 5, 2026 --

Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference Business Wire 7:00 AM

-- December 9, 2025 --

Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions PRNewswire 11:58 AM

-- November 25, 2025 --

Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference Business Wire 7:00 AM

-- November 6, 2025 --

Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress Business Wire 4:00 PM

-- October 23, 2025 --

ROCKET ALERT: Bragar Eagel & Squire, P.C. is Investigating Rocket Pharmaceuticals, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm Globe Newswire 6:03 PM

-- October 14, 2025 --

Rocket Pharmaceuticals Announces FDA Acceptance of BLA Resubmission of KRESLADI for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I) Business Wire 7:00 AM

-- October 10, 2025 --

Rocket Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:00 PM

-- September 19, 2025 --

Kuehn Law Encourages Investors of Rocket Pharmaceuticals, Inc. to Contact Law Firm PRNewswire 1:30 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software